Together, the results from this study and the studies on tamoxifen [49] and aminoflavone [50] suggest that intratumoral expression of SULT1A1 may serve as a bioactivator for some anticancer agents and as a biomarker to identify responders to those therapeutics in a subgroup of cancer patients. The gene discussed is SULT1A1; the disease is cancer.